FGAM
CPIX icon

Financial Gravity Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Financial Gravity Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$10K Sell
2,000
-4,000
-67% -$21.1K 0.01% 1190
2019
Q3 		$36K Buy
+6,000
New +$33.4K 0.03% 343

Other funds holding CPIX

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Financial Gravity Asset Management's CPIX Position: Q4 2019 in Review

Financial Gravity Asset Management reduced its Cumberland Pharmaceuticals (CPIX) stake by 67% in Q4 2019, selling an estimated $21.1K and leaving 2,000 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1190.

Financial Gravity Asset Management first reported a position in CPIX in Q3 2019 and has held it in 2 quarters since. The position peaked at $36K in Q3 2019. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2019.

  • Financial Gravity Asset Management held 2,000 shares of Cumberland Pharmaceuticals worth $10K as of Q4 2019.
  • Financial Gravity Asset Management sold 4,000 Cumberland Pharmaceuticals shares in Q4 2019, an estimated $21.1K.
  • Cumberland Pharmaceuticals made up 0.01% of Financial Gravity Asset Management's portfolio in Q4 2019, its #1190 holding.
  • Financial Gravity Asset Management first reported a position in Cumberland Pharmaceuticals in Q3 2019 and has held it in 2 quarters since.
  • Financial Gravity Asset Management's Cumberland Pharmaceuticals position peaked at $36K in Q3 2019.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.